PAULA FIGGS: Open Payments
NPI 1053416222 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,657 in 61 payments from 17 companies in 2025. Trend: 2023 $864 · 2024 $1,200 · 2025 $1,657
Food & beverage: $1,558Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $489 |
| ABBVIE INC. | 8 | $265 |
| Lilly USA, LLC | 5 | $198 |
| GlaxoSmithKline, LLC. | 10 | $163 |
| GENZYME CORPORATION | 3 | $99 |
| Genentech USA, Inc. | 3 | $93 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $74 |
| Optinose US, Inc. | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| BioCryst US Sales Co., LLC | 1 | $35 |
Products named: DUPIXENT, QULIPTA, EBGLYSS, NUCALA, Xolair, NEFFY, Xhance, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
